The Society for Cardiovascular Angiography and Interventions and the American College of Cardiology announced today that they will hold a unified interventional cardiology meeting in Chicago, March 29-April 1, 2008. The meeting will be known as “The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit.” It will be held concomitantly with the ACC Annual Scientific Session.
Researchers at the Johns Hopkins Bloomberg School of Public Health and Princeton University report that the United States continues to spend the most on health care when compared to other Organization for Economic Cooperation and Development countries.
Takeda Pharmaceuticals North America, Inc. is aware of the review of ACTOS (pioglitazone HCl) data conducted by A. Michael Lincoff, M.D., and colleagues at the Cleveland Clinic, published in the Journal of the American Medical Association, which concluded that ACTOS is associated with a significantly lower risk of heart attack, stroke or death among a diverse population of 16,390 patients with diabetes versus control therapy.
Research here shows that an obscure form of RNA, part of the protein-making machinery in all cells, might play an important role in human cancer. These ultraconserved non-coding RNAs (UCRs) have been considered ?junk? by some researchers, but a new report in the September issue of the journal Cancer Cell indicates that this may not be the case.
A vascular surgery technique pioneered at UT Southwestern Medical Center, in which veins are removed from the thigh to repair the aorta does not create blood-flow problems and painful side effects in a majority of patients, researchers report.
Being moderately overweight or obese appears to increase the risk for developing coronary heart disease events independent of traditional cardiovascular risk factors, according to a meta-analysis of previously published studies in the September 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Individuals who take vitamin D supplements appear to have a lower risk of death from any cause over an average follow-up time of six-years, according to a meta-analysis of 18 previously published studies in the September 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
Researchers from the University of Glasgow revealed that the screening and treating middle-aged adults with a family history of coronary heart disease could prevent more than 4 in 10 premature heart attacks.
Systems Biology is transforming the way scientists think about biology and disease. This novel approach to research could prompt a shake up in medical science and it might ultimately allow clinicians to predict and treat complex diseases such as diabetes, heart failure, cancer, and metabolic syndrome for which there are currently no cures.